Titre:
  • Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial.
Auteur:Demeestere, Isabelle; Niman, Samuel M; Partridge, Ann H; Diego, Daniela S; Kammler, Roswitha; Ruggeri, Monica; Colleoni, Marco Angelo; Shimizu, Chikako; Saura, Cristina; Gelmon, Karen A; Saetersdal, Anna B; Kroep, Judith R; Mailliez, Audrey; Amant, Frédéric; Ruız-Borrego, Manuel; Lee, Jeong Eon; Kataoka, Akemi; Walshe, Janice M; Takei, Junko; Borstnar, Simona; Borges, Virginia F; Saunders, Christobel; Susnjar, Snezana; Bjelic-Radisic, Vesna; Cardoso, Fatima; Meisel, Jane Lowe; Kawwass, Jennifer Fay; Spanic, Tanja; El-Abed, Sarra; Piccart-Gebhart, Martine; Korde, Larissa A; Goldhirsch, Aron; Gelber, Richard D; Pagani, Olivia; Azim, Hatem A; Peccatori, Fedro A; International Breast Cancer Study Group and the POSITIVE Trial Collaborators,
Informations sur la publication:Breast, 83, page (104547)
Statut de publication:Publié, 2025-10-01
Sujet CREF:Gynécologie
Cancérologie
Sciences biomédicales
Mots-clés:Assisted reproductive technology
Breast cancer
Ovarian reserve
Pregnancy
Premature ovarian insufficiency
MeSH keywords:Adult
Female
Humans
Pregnancy
Anti-Mullerian Hormone -- blood
Antineoplastic Agents, Hormonal
Breast Neoplasms -- drug therapy -- blood
Chemotherapy, Adjuvant
Fertility
Fertility Preservation -- methods
Follicle Stimulating Hormone -- blood
Ovarian Reserve -- physiology
Premenopause
Primary Ovarian Insufficiency -- blood
Progesterone -- blood
Prolactin -- blood
Thyrotropin -- blood
Langue:Anglais
Identificateurs:urn:issn:0960-9776
info:doi/10.1016/j.breast.2025.104547
info:pii/S0960-9776(25)00564-8
info:pmid/40743662
PMC12336806